Plunkett Research Online: VG Life Sciences Inc

VG LIFE SCIENCES INC (VGLS:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

VG Life Sciences, Inc. a biotechnology company researching new treatments and methods of detection for HIV/AIDS, Lyme disease, staph and strep, cancer and certain other autoimmune and infectious diseases......



VG Life Sciences Inc
Ticker: VGLS
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 626 334-5310
Fax:
Address: 121 Gray Avenue
Suite 200
Santa Barbara, CA 93101 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription

VG Life Sciences, Inc. a biotechnology company researching new treatments and methods of detection for HIV/AIDS, Lyme disease, staph and strep, cancer and certain other autoimmune and infectious diseases......See More See More

Auditor: KWCO, PC
Legal Advisor: Robert A. Forrester
$USD, In whole numbers,
except marked * or %
20142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: